The AVYIA Journal
All Articles · Page 2
The latest ketamine research explained in plain language, real patient case studies, and practical guides for your mental health.
Archive
Page 2 of 7
UK Slow-Release Ketamine Tablet Trial Shows Reduced Relapse in Depression: Phase 2 Results
A UK Phase 2 trial shows slow-release oral ketamine reduces depression relapse by 20% over 13 weeks, offering a convenient and scalable alternative to IV treatment.
KADS Trial Shows Rapid Suicidal Ideation Reduction with Ketamine: 88% Remission in 90 Minutes
The KADS trial found subcutaneous ketamine reduced suicidal ideation in 88% of patients within 90 minutes, offering rapid relief for treatment-resistant depression.
Ketamine for Cancer and Chronic Pain Management: Insights from Frontiers in Pharmacology
A 2020 review in Frontiers in Pharmacology supports ketamine as a fast, opioid-sparing option for cancer and chronic pain, with benefits across multiple delivery methods.
Ketamine vs. Ketorolac in Veterans: Both Reduce PTSD and Pain, Ketamine Well Tolerated
A study in U.S. veterans found both ketamine and ketorolac reduce PTSD and pain symptoms, but ketamine was better tolerated and showed lasting psychological benefits.
Repurposing Ketamine to Treat Cocaine Use Disorder: AI Prediction, Clinical Validation, and Mechanistic Insights
A 2023 study in Addiction confirms ketamine's effectiveness for cocaine use disorder using AI prediction, clinical validation, and mechanistic modeling of action.
AI-Based Study Links Ketamine to 2–4× Higher Remission in Cocaine Use Disorder
An AI-powered study shows ketamine may increase cocaine use disorder remission rates by 2–4x. Real-world data points to reduced relapse and sustained abstinence.
Ketamine and Addiction: Alpha Psychiatry 2024 Review Shows Reduced Cravings and Relapse
A 2024 review in Alpha Psychiatry shows ketamine may reduce cravings and relapse in alcohol, opioid, and cocaine addiction—especially when combined with therapy.
Systematic Review: Ketamine Shows Short-Term Relief for Depression with Enhanced Outcomes When Combined with Cognitive Behavioral Therapy
A 2023 Cureus review shows ketamine offers fast depression relief, but combining it with CBT leads to longer-lasting results, fewer relapses, and better outcomes.
Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression
A 2022 real-world study shows repeated ketamine infusions reduce bipolar depression symptoms by up to 70%, with fast relief and high tolerability in outpatient care.
Ketamine-Assisted Psychotherapy for Bipolar Depression: Rapid Relief Within 40 Minutes
A clinical review shows ketamine-assisted psychotherapy delivers rapid relief from bipolar depression and suicidal thoughts—often within 40 minutes of treatment.
At-Home Ketamine via Telehealth: Large Study Shows Significant Anxiety Improvement
A 2023 study of 1,247 patients shows that at-home ketamine via telehealth reduces anxiety in over 60% of users within 4 weeks—safe, scalable, and effective.
Ketamine for Treatment of PTSD: State of the Field Review
This 2023 field review confirms ketamine’s growing role in PTSD treatment, highlighting rapid symptom relief, biological mechanisms, and therapy integration benefits.
OnlineTalk to ProviderCall us